Blar i ODA Open Digital Archive på forfatter "Medhus, Asle Wilhelm"
-
Fatigue in patients with newly diagnosed inflammatory bowel disease: Results from a prospective inception cohort, the IBSEN III study
Holten, Kristina Ingeborg; Bernklev, Tomm; Opheim, Randi; Johansen, Ingunn; Olsen, Bjørn Christian Elias Grova; Lund, Charlotte; Strande, Vibeke; Medhus, Asle Wilhelm; Perminow, Gøri Margrete; Bengtson, May-Bente; Boyar Cetinkaya, Raziye; Vatn, Simen Svendsen; Frigstad, Svein Oskar; Aabrekk, Tone Bergene; Detlie, Trond Espen; Hovde, Øistein; Kristensen, Vendel Ailin; Småstuen, Milada Cvancarova; Henriksen, Magne; Huppertz-Hauss, Gert; Høivik, Marte Lie; Jelsness-Jørgensen, Lars-Petter (Peer reviewed; Journal article, 2023)Background and aims: Although fatigue is common in inflammatory bowel disease (IBD), its pathogenesis remains unclear. This study aimed to determine the prevalence of fatigue and its associated factors in a cohort of ... -
Intraoperative distensibility measurement in POEM for achalasia: impact on patient outcome and associations with other outcome variables at 1-year follow-up
Evensen, Helge; Sandstad, Olav; Larssen, Lene; Hagen, Milada; Kristensen, Vendel Ailin; Søvik, Torgeir Thorson; Schulz, Anselm; Hauge, Truls; Medhus, Asle Wilhelm (Peer reviewed; Journal article, 2023)Background and aims The functional luminal imaging probe (FLIP) can provide measurements of lower esophageal sphincter (LES) distensibility. Studies report that use of intraoperative FLIP examination during peroral ... -
One year comprehensive prospective follow-up of achalasia patients after peroral endoscopic myotomy
Evensen, Helge; Småstuen, Milada Cvancarova; Schulz, Anselm; Kristensen, Vendel Ailin; Larssen, Lene; Skattum, Jorunn Pettersen; Sandstad, Olav; Hauge, Truls; Medhus, Asle Wilhelm (Peer reviewed; Journal article, 2021)Peroral endoscopic myotomy (POEM) is an established therapy for achalasia, but outcome evaluation has often been limited to Eckardt score (ES). The present study was aimed to improve knowledge about outcome evaluation and ... -
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring
Wiken, Thea H.; Høivik, Marte Lie; Buer, Lydia Celine Tansem; Warren, David J.; Bolstad, Nils; Moum, Bjørn Allan; Anisdahl, Karoline; Småstuen, Milada Cvancarova; Medhus, Asle Wilhelm (Peer reviewed; Journal article, 2023)Objective: Vedolizumab (VDZ) for subcutaneous (SC) administration has recently become available. We aimed to assess feasibility, safety and clinical outcome when switching from intravenous (IV) to SC VDZ maintenance ...